2017 ESC/EACTS Guidelines for the management of valvular heart disease
Tóm tắt
Từ khóa
Tài liệu tham khảo
Popescu, 2009, European Association of Echocardiography recommendations for training, competence, and quality improvement in echocardiography, Eur J Echocardiogr, 10, 893, 10.1093/ejechocard/jep151
Lancellotti, 2013, Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging, Eur Heart J Cardiovasc Imaging, 14, 611, 10.1093/ehjci/jet105
Baumgartner, 2009, Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice, Eur J Echocardiogr, 10, 1, 10.1093/ejechocard/jen303
Baumgartner, 2017, Focus update on the echocardiographic assessment of aortic valve stenosis: EAE/ASE recommendations for clinical practice, Eur Heart J Cardiovasc Imaging, 18, 254, 10.1093/ehjci/jew335
Rudski, 2010, Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography, J Am Soc Echocardiogr, 23, 685, 10.1016/j.echo.2010.05.010
Lancellotti, 2010, European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease), Eur J Echocardiogr, 11, 223, 10.1093/ejechocard/jeq030
Lancellotti, 2010, European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease), Eur J Echocardiogr, 11, 307, 10.1093/ejechocard/jeq031
Henri, 2014, Exercise testing and stress imaging in valvular heart disease, Can J Cardiol, 30, 1012, 10.1016/j.cjca.2014.03.013
Picano, 2009, The emerging role of exercise testing and stress echocardiography in valvular heart disease, J Am Coll Cardiol, 54, 2251, 10.1016/j.jacc.2009.07.046
Monin, 2003, Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics, Circulation, 108, 319, 10.1161/01.CIR.0000079171.43055.46
American College of Cardiology Foundation Task Force on Expert Consensus Documents, 2010, ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents, J Am Coll Cardiol, 55, 2614, 10.1016/j.jacc.2009.11.011
Cueff, 2011, Measurement of aortic valve calcification using multislice computed tomography: correlation with haemodynamic severity of aortic stenosis and clinical implication for patients with low ejection fraction, Heart, 97, 721, 10.1136/hrt.2010.198853
Clavel, 2013, The complex nature of discordant severe calcified aortic valve disease grading: new insights from combined Doppler echocardiographic and computed tomographic study, J Am Coll Cardiol, 62, 2329, 10.1016/j.jacc.2013.08.1621
Bergler-Klein, 2014, The role of biomarkers in valvular heart disease: focus on natriuretic peptides, Can J Cardiol, 30, 1027, 10.1016/j.cjca.2014.07.014
Windecker, 2014, 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), Eur Heart J, 35, 2541, 10.1093/eurheartj/ehu278
Osnabrugge, 2014, Performance of EuroSCORE II in a large US database: implications for transcatheter aortic valve implantation, Eur J Cardiothorac Surg, 46, 400, 10.1093/ejcts/ezu033
Barili, 2013, Does EuroSCORE II perform better than its original versions? A multicentre validation study, Eur Heart J, 34, 22, 10.1093/eurheartj/ehs342
Iung, 2014, Predictive factors of early mortality after transcatheter aortic valve implantation: individual risk assessment using a simple score, Heart, 100, 1016, 10.1136/heartjnl-2013-305314
Edwards, 2016, Development and validation of a risk prediction model for in-hospital mortality after transcatheter aortic valve replacement, JAMA Cardiol, 1, 46, 10.1001/jamacardio.2015.0326
Arnold, 2014, Predictors of poor outcomes after transcatheter aortic valve replacement: results from the PARTNER (Placement of Aortic Transcatheter Valve) trial, Circulation, 129, 2682, 10.1161/CIRCULATIONAHA.113.007477
Puri, 2016, TAVI or no TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantation, Eur Heart J, 37, 2217, 10.1093/eurheartj/ehv756
Gagne, 2011, A combined comorbidity score predicted mortality in elderly patients better than existing scores, J Clin Epidemiol, 64, 749, 10.1016/j.jclinepi.2010.10.004
Gunter, 2013, Impact of preoperative chronic lung disease on survival after surgical aortic valve replacement, Ann Thorac Surg, 96, 1322, 10.1016/j.athoracsur.2013.05.061
Allende, 2014, Advanced chronic kidney disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes and prognostic markers from a large cohort of patients, Eur Heart J, 35, 2685, 10.1093/eurheartj/ehu175
Stortecky, 2012, Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation, JACC Cardiovasc Interv, 5, 489, 10.1016/j.jcin.2012.02.012
Puls, 2014, Impact of frailty on short- and long-term morbidity and mortality after transcatheter aortic valve implantation: risk assessment by Katz Index of activities of daily living, EuroIntervention, 10, 609, 10.4244/EIJY14M08_03
Habib, 2015, 2015 ESC Guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM), Eur Heart J, 36, 3075, 10.1093/eurheartj/ehv319
Gerber, 2009, Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics, Circulation, 119, 1541, 10.1161/CIRCULATIONAHA.109.191959
Remenyi, 2013, Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease, Nat Rev Cardiol, 10, 284, 10.1038/nrcardio.2013.34
Chambers, Standards defining a “heart valve centre”: ESC Working Group on Valvular Heart Disease and European Association for Cardiothoracic Surgery viewpoint
Chambers, 2013, Specialist valve clinics: recommendations from the British Heart Valve Society working group on improving quality in the delivery of care for patients with heart valve disease, Heart, 99, 1714, 10.1136/heartjnl-2013-303754
Badheka, 2015, Effect of hospital volume on outcomes of transcatheter aortic valve implantation, Am J Cardiol, 116, 587, 10.1016/j.amjcard.2015.05.019
Kilic, 2013, Operative outcomes in mitral valve surgery: combined effect of surgeon and hospital volume in a population-based analysis, J Thorac Cardiovasc Surg, 146, 638, 10.1016/j.jtcvs.2012.07.070
Pagano, 2016, EACTS clinical statement: guidance for the provision of adult cardiac surgery, Eur J Cardiothorac Surg, 50, 1006, 10.1093/ejcts/ezw300
Kirchhof, 2016, 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: the Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC: endorsed by the European Stroke Organisation (ESO), Eur Heart J, 37, 2893, 10.1093/eurheartj/ehw210
Breithardt, 2014, Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial, Eur Heart J, 35, 3377, 10.1093/eurheartj/ehu305
Avezum, 2015, Apixaban in comparison with warfarin in patients with atrial fibrillation and valvular heart disease: findings from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial, Circulation, 132, 624, 10.1161/CIRCULATIONAHA.114.014807
Ezekowitz, 2016, Comparison of dabigatran and warfarin in patients with atrial fibrillation and valvular heart disease: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulant Therapy), Circulation, 134, 589, 10.1161/CIRCULATIONAHA.115.020950
De Caterina, 2017, Valvular heart disease patients on edoxaban or warfarin in the ENGAGE AF-TIMI 48 Trial, J Am Coll Cardiol, 69, 1372, 10.1016/j.jacc.2016.12.031
Iung, 2014, The optimal management of anti-thrombotic therapy after valve replacement: certainties and uncertainties, Eur Heart J, 35, 2942, 10.1093/eurheartj/ehu365
Heidbuchel, 2015, Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation, Europace, 17, 1467, 10.1093/europace/euv309
Gillinov, 2015, Surgical ablation of atrial fibrillation during mitral-valve surgery, N Engl J Med, 372, 1399, 10.1056/NEJMoa1500528
Eikelboom, 2013, Dabigatran versus warfarin in patients with mechanical heart valves, N Engl J Med, 369, 1206, 10.1056/NEJMoa1300615
Tsai, 2015, Surgical left atrial appendage occlusion during cardiac surgery for patients with atrial fibrillation: a meta-analysis, Eur J Cardiothorac Surg, 47, 847, 10.1093/ejcts/ezu291
Iung, 2003, A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease, Eur Heart J, 24, 1231, 10.1016/S0195-668X(03)00201-X
le Polain de Waroux, 2007, Functional anatomy of aortic regurgitation: accuracy, prediction of surgical repairability, and outcome implications of transesophageal echocardiography, Circulation, 116, I264, 10.1161/CIRCULATIONAHA.106.680074
Lansac, 2008, A lesional classification to standardize surgical management of aortic insufficiency towards valve repair, Eur J Cardiothorac Surg, 33, 872, 10.1016/j.ejcts.2007.12.033
Sambola, 2008, Prognostic value of preoperative indexed end-systolic left ventricle diameter in the outcome after surgery in patients with chronic aortic regurgitation, Am Heart J, 155, 1114, 10.1016/j.ahj.2007.12.025
Marciniak, 2009, Myocardial deformation abnormalities in patients with aortic regurgitation: a strain rate imaging study, Eur J Echocardiogr, 10, 112, 10.1093/ejechocard/jen185
Goldstein, 2015, Multimodality imaging of diseases of the thoracic aorta in adults: from the American Society of Echocardiography and the European Association of Cardiovascular Imaging: endorsed by the Society of Cardiovascular Computed Tomography and Society for Cardiovascular Magnetic Resonance, J Am Soc Echocardiogr, 28, 119, 10.1016/j.echo.2014.11.015
Lang, 2015, Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging, J Am Soc Echocardiogr, 28, 1, 10.1016/j.echo.2014.10.003
Freeman, 2013, CT and MRI assessment of the aortic root and ascending aorta, AJR Am J Roentgenol, 200, W581, 10.2214/AJR.12.9531
Amsallem, 2015, Comparative assessment of ascending aortic aneurysms in Marfan patients using ECG-gated computerized tomographic angiography versus trans-thoracic echocardiography, Int J Cardiol, 184, 22, 10.1016/j.ijcard.2015.01.086
Erbel, 2014, ESC Committee for Practice Guidelines. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC), Eur Heart J, 35, 2873, 10.1093/eurheartj/ehu281
Chaliki, 2002, Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function, Circulation, 106, 2687, 10.1161/01.CIR.0000038498.59829.38
Tornos, 2006, Long-term outcome of surgically treated aortic regurgitation: influence of guideline adherence toward early surgery, J Am Coll Cardiol, 47, 1012, 10.1016/j.jacc.2005.10.049
Jondeau, 2012, Aortic event rate in the Marfan population: a cohort study, Circulation, 125, 226, 10.1161/CIRCULATIONAHA.111.054676
Jondeau, 2016, International Registry of Patients Carrying TGFBR1 or TGFBR2 Mutations: results of the MAC (Montalcino Aortic Consortium), Circ Cardiovasc Genet, 9, 548, 10.1161/CIRCGENETICS.116.001485
Borger, 2004, Should the ascending aorta be replaced more frequently in patients with bicuspid aortic valve disease?, J Thorac Cardiovasc Surg, 128, 677, 10.1016/j.jtcvs.2004.07.009
Aicher, 2010, Aortic valve repair leads to a low incidence of valve-related complications, Eur J Cardiothorac Surg, 37, 127, 10.1016/j.ejcts.2009.06.021
Vohra, 2013, Valve-preserving surgery on the bicuspid aortic valve, Eur J Cardiothorac Surg, 43, 888, 10.1093/ejcts/ezs664
Arabkhani, 2015, Reported outcome after valve-sparing aortic root replacement for aortic root aneurysm: a systematic review and meta-analysis, Ann Thorac Surg, 100, 1126, 10.1016/j.athoracsur.2015.05.093
Lansac, 2016, Long-term results of external aortic ring annuloplasty for aortic valve repair, Eur J Cardiothorac Surg, 50, 350, 10.1093/ejcts/ezw070
Dujardin, 1999, Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study, Circulation, 99, 1851, 10.1161/01.CIR.99.14.1851
Klodas, 1997, Optimizing timing of surgical correction in patients with severe aortic regurgitation: role of symptoms, J Am Coll Cardiol, 30, 746, 10.1016/S0735-1097(97)00205-2
Zendaoui, 2011, Usefulness of carvedilol in the treatment of chronic aortic valve regurgitation, Circ Heart Fail, 4, 207, 10.1161/CIRCHEARTFAILURE.110.958512
Elder, 2011, The impact of renin-angiotensin-aldosterone system blockade on heart failure outcomes and mortality in patients identified to have aortic regurgitation: a large population cohort study, J Am Coll Cardiol, 58, 2084, 10.1016/j.jacc.2011.07.043
Lacro, 2014, Atenolol versus losartan in children and young adults with Marfan’s syndrome, N Engl J Med, 371, 2061, 10.1056/NEJMoa1404731
Milleron, 2015, Marfan Sartan: a randomized, double-blind, placebo-controlled trial, Eur Heart J, 36, 2160, 10.1093/eurheartj/ehv151
Forteza, 2016, Efficacy of losartan vs. atenolol for the prevention of aortic dilation in Marfan syndrome: a randomized clinical trial, Eur Heart J, 37, 978, 10.1093/eurheartj/ehv575
Meijboom, 2005, Pregnancy and aortic root growth in the Marfan syndrome: a prospective study, Eur Heart J, 26, 914, 10.1093/eurheartj/ehi103
McKellar, 2011, Frequency of cardiovascular events in women with a congenitally bicuspid aortic valve in a single community and effect of pregnancy on events, Am J Cardiol, 107, 96, 10.1016/j.amjcard.2010.08.061
Braverman, 2015, Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 7: aortic diseases, including Marfan syndrome: a scientific statement from the American Heart Association and American College of Cardiology, Circulation, 132, e303, 10.1161/CIR.0000000000000243
Pizarro, 2011, Prospective validation of the prognostic usefulness of B-type natriuretic peptide in asymptomatic patients with chronic severe aortic regurgitation, J Am Coll Cardiol, 58, 1705, 10.1016/j.jacc.2011.07.016
Weisenberg, 2013, Mid-term echocardiographic progression of patients with moderate aortic regurgitation: implications for aortic valve surgery, J Heart Valve Dis, 22, 192
Levy, 2008, Aortic valve replacement for low-flow/low-gradient aortic stenosis operative risk stratification and long-term outcome: a European multicenter study, J Am Coll Cardiol, 51, 1466, 10.1016/j.jacc.2007.10.067
Hachicha, 2007, Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival, Circulation, 115, 2856, 10.1161/CIRCULATIONAHA.106.668681
Clavel, 2012, Outcome of patients with aortic stenosis, small valve area, and low-flow, low-gradient despite preserved left ventricular ejection fraction, J Am Coll Cardiol, 60, 1259, 10.1016/j.jacc.2011.12.054
Clavel, 2014, Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis: results of an international registry study, J Am Coll Cardiol, 64, 1202, 10.1016/j.jacc.2014.05.066
Mehrotra, 2013, Differential left ventricular remodelling and longitudinal function distinguishes low flow from normal-flow preserved ejection fraction low-gradient severe aortic stenosis, Eur Heart J, 34, 1906, 10.1093/eurheartj/eht094
Tribouilloy, 2015, Low-gradient, low-flow severe aortic stenosis with preserved left ventricular ejection fraction: characteristics, outcome, and implications for surgery, J Am Coll Cardiol, 65, 55, 10.1016/j.jacc.2014.09.080
Jander, 2011, Outcome of patients with low-gradient “severe” aortic stenosis and preserved ejection fraction, Circulation, 123, 887, 10.1161/CIRCULATIONAHA.110.983510
Rafique, 2009, Meta-analysis of prognostic value of stress testing in patients with asymptomatic severe aortic stenosis, Am J Cardiol, 104, 972, 10.1016/j.amjcard.2009.05.044
Marechaux, 2010, Usefulness of exercise-stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis, Eur Heart J, 31, 1390, 10.1093/eurheartj/ehq076
Zamorano, 2011, EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease, Eur Heart J, 32, 2189, 10.1093/eurheartj/ehr259
Azevedo, 2010, Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease, J Am Coll Cardiol, 56, 278, 10.1016/j.jacc.2009.12.074
Bergler-Klein, 2004, Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis, Circulation, 109, 2302, 10.1161/01.CIR.0000126825.50903.18
Clavel, 2014, B-type natriuretic peptide clinical activation in aortic stenosis: impact on long-term survival, J Am Coll Cardiol, 63, 2016, 10.1016/j.jacc.2014.02.581
Leon, 2010, Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery, N Engl J Med, 363, 1597, 10.1056/NEJMoa1008232
Rosenhek, 2000, Predictors of outcome in severe, asymptomatic aortic stenosis, N Engl J Med, 343, 611, 10.1056/NEJM200008313430903
Thourani, 2015, Contemporary real-world outcomes of surgical aortic valve replacement in 141,905 low-risk, intermediate-risk, and high-risk patients, Ann Thorac Surg, 99, 55, 10.1016/j.athoracsur.2014.06.050
Deeb, 2016, 3-year outcomes in high-risk patients who underwent surgical or transcatheter aortic valve replacement, J Am Coll Cardiol, 67, 2565, 10.1016/j.jacc.2016.03.506
Smith, 2011, Transcatheter versus surgical aortic-valve replacement in high-risk patients, N Engl J Med, 364, 2187, 10.1056/NEJMoa1103510
Mack, 2015, 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial, Lancet, 385, 2477, 10.1016/S0140-6736(15)60308-7
Adams, 2014, Transcatheter aortic-valve replacement with a self-expanding prosthesis, N Engl J Med, 370, 1790, 10.1056/NEJMoa1400590
Thyregod, 2015, Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial, J Am Coll Cardiol, 65, 2184, 10.1016/j.jacc.2015.03.014
Leon, 2016, Transcatheter or surgical aortic-valve replacement in intermediate-risk patients, N Engl J Med, 374, 1609, 10.1056/NEJMoa1514616
Thourani, 2016, Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis, Lancet, 387, 2218, 10.1016/S0140-6736(16)30073-3
Siontis, 2016, Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials, Eur Heart J, 37, 3503, 10.1093/eurheartj/ehw225
Reardon, 2017, Surgical or transcatheter aortic-valve replacement in intermediate-risk patients, N Engl J Med, 376, 1321, 10.1056/NEJMoa1700456
Rogers, 2017, Society of Thoracic Surgeons score variance results in risk reclassification of patients undergoing transcatheter aortic valve replacement, JAMA Cardiol, 2, 455, 10.1001/jamacardio.2016.4132
Tribouilloy, 2009, Outcome after aortic valve replacement for low-flow/low-gradient aortic stenosis without contractile reserve on dobutamine stress echocardiography, J Am Coll Cardiol, 53, 1865, 10.1016/j.jacc.2009.02.026
Fougeres, 2012, Outcomes of pseudo-severe aortic stenosis under conservative treatment, Eur Heart J, 33, 2426, 10.1093/eurheartj/ehs176
Genereux, 2016, Natural history, diagnostic approaches, and therapeutic strategies for patients with asymptomatic severe aortic stenosis, J Am Coll Cardiol, 67, 2263, 10.1016/j.jacc.2016.02.057
Das, 2005, Exercise testing to stratify risk in aortic stenosis, Eur Heart J, 26, 1309, 10.1093/eurheartj/ehi250
Rosenhek, 2010, Natural history of very severe aortic stenosis, Circulation, 121, 151, 10.1161/CIRCULATIONAHA.109.894170
Cioffi, 2011, Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis, Heart, 97, 301, 10.1136/hrt.2010.192997
Dahl, 2012, Global strain in severe aortic valve stenosis: relation to clinical outcome after aortic valve replacement, Circ Cardiovasc Imaging, 5, 613, 10.1161/CIRCIMAGING.112.973834
Zlotnick, 2013, Effect of preoperative pulmonary hypertension on outcomes in patients with severe aortic stenosis following surgical aortic valve replacement, Am J Cardiol, 112, 1635, 10.1016/j.amjcard.2013.07.025
Rossebo, 2008, Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis, N Engl J Med, 359, 1343, 10.1056/NEJMoa0804602
Ponikowski, 2016, 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC, Eur Heart J, 37, 2129, 10.1093/eurheartj/ehw128
Smith, 2004, Should coronary artery bypass graft surgery patients with mild or moderate aortic stenosis undergo concomitant aortic valve replacement? A decision analysis approach to the surgical dilemma, J Am Coll Cardiol, 44, 1241, 10.1016/j.jacc.2004.06.031
Baumgartner, 2010, ESC Guidelines for the management of grown-up congenital heart disease (new version 2010), Eur Heart J, 31, 2915, 10.1093/eurheartj/ehq249
De Bonis, 2016, Surgical and interventional management of mitral valve regurgitation: a position statement from the European Society of Cardiology Working Groups on Cardiovascular Surgery and Valvular Heart Disease, Eur Heart J, 37, 133, 10.1093/eurheartj/ehv322
Monin, 2005, Functional assessment of mitral regurgitation by transthoracic echocardiography using standardized imaging planes diagnostic accuracy and outcome implications, J Am Coll Cardiol, 46, 302, 10.1016/j.jacc.2005.03.064
Lancellotti, 2005, Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation, Eur Heart J, 26, 1528, 10.1093/eurheartj/ehi189
Magne, 2010, Exercise pulmonary hypertension in asymptomatic degenerative mitral regurgitation, Circulation, 122, 33, 10.1161/CIRCULATIONAHA.110.938241
Pizarro, 2009, Prospective validation of the prognostic usefulness of brain natriuretic peptide in asymptomatic patients with chronic severe mitral regurgitation, J Am Coll Cardiol, 54, 1099, 10.1016/j.jacc.2009.06.013
Tribouilloy, 1999, Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications, Circulation, 99, 400, 10.1161/01.CIR.99.3.400
Enriquez-Sarano, 1994, Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation, Circulation, 90, 830, 10.1161/01.CIR.90.2.830
Badhwar, 2012, Longitudinal outcome of isolated mitral repair in older patients: results from 14,604 procedures performed from 1991 to 2007, Ann Thorac Surg, 94, 1870, 10.1016/j.athoracsur.2012.05.105
Le Tourneau, 2010, Echocardiography predictors and prognostic value of pulmonary artery systolic pressure in chronic organic mitral regurgitation, Heart, 96, 1311, 10.1136/hrt.2009.186486
Tribouilloy, 2009, Survival implication of left ventricular end-systolic diameter in mitral regurgitation due to flail leaflets a long-term follow-up multicenter study, J Am Coll Cardiol, 54, 1961, 10.1016/j.jacc.2009.06.047
Rosenhek, 2006, Outcome of watchful waiting in asymptomatic severe mitral regurgitation, Circulation, 113, 2238, 10.1161/CIRCULATIONAHA.105.599175
Gammie, 2007, Influence of hospital procedural volume on care process and mortality for patients undergoing elective surgery for mitral regurgitation, Circulation, 115, 881, 10.1161/CIRCULATIONAHA.106.634436
Bolling, 2010, Predictors of mitral valve repair: clinical and surgeon factors, Ann Thorac Surg, 90, 1904, 10.1016/j.athoracsur.2010.07.062
Feldman, 2011, Percutaneous repair or surgery for mitral regurgitation, N Engl J Med, 364, 1395, 10.1056/NEJMoa1009355
Feldman, 2015, Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II, J Am Coll Cardiol, 66, 2844, 10.1016/j.jacc.2015.10.018
Enriquez-Sarano, 1994, Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: results and clinical implications, J Am Coll Cardiol, 24, 1536, 10.1016/0735-1097(94)90151-1
Haan, 2004, Selecting patients with mitral regurgitation and left ventricular dysfunction for isolated mitral valve surgery, Ann Thorac Surg, 78, 820, 10.1016/j.athoracsur.2004.04.003
Samad, 2011, Impact of early surgery on survival of patients with severe mitral regurgitation, Heart, 97, 221, 10.1136/hrt.2010.202432
Levine, 2005, Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts, Circulation, 112, 745, 10.1161/CIRCULATIONAHA.104.486720
Grigioni, 2001, Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment, Circulation, 103, 1759, 10.1161/01.CIR.103.13.1759
Acker, 2014, Mitral-valve repair versus replacement for severe ischemic mitral regurgitation, N Engl J Med, 370, 23, 10.1056/NEJMoa1312808
Mihaljevic, 2007, Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation, J Am Coll Cardiol, 49, 2191, 10.1016/j.jacc.2007.02.043
Wu, 2005, Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction, J Am Coll Cardiol, 45, 381, 10.1016/j.jacc.2004.09.073
Mauri, 2013, 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation, J Am Coll Cardiol, 62, 317, 10.1016/j.jacc.2013.04.030
Maisano, 2013, Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe, J Am Coll Cardiol, 62, 1052, 10.1016/j.jacc.2013.02.094
Michler, 2016, Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation, N Engl J Med, 374, 1932, 10.1056/NEJMoa1602003
Iung, 2014, Epidemiology of acquired valvular heart disease, Can J Cardiol, 30, 962, 10.1016/j.cjca.2014.03.022
Abramowitz, 2015, Mitral annulus calcification, J Am Coll Cardiol, 66, 1934, 10.1016/j.jacc.2015.08.872
Bouleti, 2012, Late results of percutaneous mitral commissurotomy up to 20 years: development and validation of a risk score predicting late functional results from a series of 912 patients, Circulation, 125, 2119, 10.1161/CIRCULATIONAHA.111.055905
Wilkins, 1988, Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation, Br Heart J, 60, 299, 10.1136/hrt.60.4.299
Nunes, 2014, The echo score revisited: Impact of incorporating commissural morphology and leaflet displacement to the prediction of outcome for patients undergoing percutaneous mitral valvuloplasty, Circulation, 129, 886, 10.1161/CIRCULATIONAHA.113.001252
Badheka, 2014, Balloon mitral valvuloplasty in the United States: a 13-year perspective, Am J Med, 127, 10.1016/j.amjmed.2014.02.025
Tomai, 2014, Twenty year follow-up after successful percutaneous balloon mitral valvuloplasty in a large contemporary series of patients with mitral stenosis, Int J Cardiol, 177, 881, 10.1016/j.ijcard.2014.10.040
Bouleti, 2014, Relationship between valve calcification and long-term results of percutaneous mitral commissurotomy for rheumatic mitral stenosis, Circ Cardiovasc Interv, 7, 381, 10.1161/CIRCINTERVENTIONS.113.000858
Iung, 1996, Immediate results of percutaneous mitral commissurotomy. A predictive model on a series of 1514 patients, Circulation, 94, 2124, 10.1161/01.CIR.94.9.2124
Bouleti, 2013, Reinterventions after percutaneous mitral commissurotomy during long-term follow-up, up to 20 years: the role of repeat percutaneous mitral commissurotomy, Eur Heart J, 34, 1923, 10.1093/eurheartj/eht097
Guerrero, 2016, Transcatheter mitral valve replacement in native mitral valve disease with severe mitral annular calcification: results from the first multicenter global registry, JACC Cardiovasc Interv, 9, 1361, 10.1016/j.jcin.2016.04.022
Song, 2007, Percutaneous mitral valvuloplasty versus surgical treatment in mitral stenosis with severe tricuspid regurgitation, Circulation, 116, I-246, 10.1161/CIRCULATIONAHA.107.678151
Sousa, 2012, Infective endocarditis in intravenous drug abusers: an update, Eur J Clin Microbiol Infect Dis, 31, 2905, 10.1007/s10096-012-1675-x
Park, 2016, Quantification of right ventricular volume and function using single-beat three-dimensional echocardiography: a validation study with cardiac magnetic resonance, J Am Soc Echocardiogr, 29, 392, 10.1016/j.echo.2016.01.010
Dreyfus, 2005, Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair?, Ann Thorac Surg, 79, 127, 10.1016/j.athoracsur.2004.06.057
Van de Veire, 2011, Tricuspid annuloplasty prevents right ventricular dilatation and progression of tricuspid regurgitation in patients with tricuspid annular dilatation undergoing mitral valve repair, J Thorac Cardiovasc Surg, 141, 1431, 10.1016/j.jtcvs.2010.05.050
Nath, 2004, Impact of tricuspid regurgitation on long-term survival, J Am Coll Cardiol, 43, 405, 10.1016/j.jacc.2003.09.036
Kammerlander, 2014, Right ventricular dysfunction, but not tricuspid regurgitation, is associated with outcome late after left heart valve procedure, J Am Coll Cardiol, 64, 2633, 10.1016/j.jacc.2014.09.062
Chikwe, 2015, Impact of concomitant tricuspid annuloplasty on tricuspid regurgitation, right ventricular function, and pulmonary artery hypertension after repair of mitral valve prolapse, J Am Coll Cardiol, 65, 1931, 10.1016/j.jacc.2015.01.059
Chang, 2006, Long-term clinical results of tricuspid valve replacement, Ann Thorac Surg, 81, 1317, 10.1016/j.athoracsur.2005.11.005
Filsoufi, 2005, Long-term outcomes of tricuspid valve replacement in the current era, Ann Thorac Surg, 80, 845, 10.1016/j.athoracsur.2004.12.019
Yeter, 2010, Tricuspid balloon valvuloplasty to treat tricuspid stenosis, J Heart Valve Dis, 19, 159
Hammermeister, 2000, Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial, J Am Coll Cardiol, 36, 1152, 10.1016/S0735-1097(00)00834-2
Oxenham, 2003, Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses, Heart, 89, 715, 10.1136/heart.89.7.715
Stassano, 2009, Aortic valve replacement: a prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 years, J Am Coll Cardiol, 54, 1862, 10.1016/j.jacc.2009.07.032
Capodanno, 2017, Standardised definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves – a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), Eur Heart J, 10.1093/eurheartj/ehx303
Zoghbi, 2009, Recommendations for evaluation of prosthetic valves with echocardiography and Doppler ultrasound: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography, J Am Soc Echocardiogr, 22, 975, 10.1016/j.echo.2009.07.013
Lancellotti, 2016, Recommendations for the imaging assessment of prosthetic heart valves: a report from the European Association of Cardiovascular Imaging endorsed by the Chinese Society of Echocardiography, the Inter-American Society of Echocardiography, and the Brazilian Department of Cardiovascular Imaging, Eur Heart J Cardiovasc Imaging, 17, 589, 10.1093/ehjci/jew025
Butchart, 2005, Recommendations for the management of patients after heart valve surgery, Eur Heart J, 26, 2463, 10.1093/eurheartj/ehi426
Brennan, 2012, Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database, J Am Coll Cardiol, 60, 971, 10.1016/j.jacc.2012.05.029
Merie, 2012, Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding, JAMA, 308, 2118, 10.1001/jama.2012.54506
Rivas-Gandara, 2008, Enoxaparin as bridging anticoagulant treatment in cardiac surgery, Heart, 94, 205, 10.1136/hrt.2006.109967
Meurin, 2006, Low-molecular-weight heparin as a bridging anticoagulant early after mechanical heart valve replacement, Circulation, 113, 564, 10.1161/CIRCULATIONAHA.105.575571
Laffort, 2000, Early and long-term (one-year) effects of the association of aspirin and oral anticoagulant on thrombi and morbidity after replacement of the mitral valve with the St. Jude medical prosthesis: a clinical and transesophageal echocardiographic study, J Am Coll Cardiol, 35, 739, 10.1016/S0735-1097(99)00598-7
Vavuranakis, 2016, Dual or single antiplatelet therapy after transcatheter aortic valve implantation? A systematic review and meta-analysis, Curr Pharm Des, 22, 4596, 10.2174/1381612822666160601110716
Chakravarty, 2017, Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study, Lancet, 389, 2383, 10.1016/S0140-6736(17)30757-2
Cannegieter, 1994, Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses, Circulation, 89, 635, 10.1161/01.CIR.89.2.635
Mok, 1985, Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial, Circulation, 72, 1059, 10.1161/01.CIR.72.5.1059
Heneghan, 2012, Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data, Lancet, 379, 322, 10.1016/S0140-6736(11)61294-4
Fiedler, 2015, Duration of triple therapy in patients requiring oral anticoagulation after drug-eluting stent implantation: the ISAR-TRIPLE Trial, J Am Coll Cardiol, 65, 1619, 10.1016/j.jacc.2015.02.050
Gibson, 2016, Prevention of bleeding in patients with atrial fibrillation undergoing PCI, N Engl J Med, 375, 2423, 10.1056/NEJMoa1611594
Dewilde, 2013, Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial, Lancet, 381, 1107, 10.1016/S0140-6736(12)62177-1
Lamberts, 2014, Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study, Circulation, 129, 1577, 10.1161/CIRCULATIONAHA.113.004834
Torella, 2010, LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: results from the “LOWERING-IT” Trial, Am Heart J, 160, 171, 10.1016/j.ahj.2010.05.005
Puskas, 2014, Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-X valve anticoagulation clinical trial randomized Food and Drug Administration investigational device exemption trial, J Thorac Cardiovasc Surg, 147, 1202, 10.1016/j.jtcvs.2014.01.004
Koertke, 2015, Telemedicine-guided, very low-dose international normalized ratio self-control in patients with mechanical heart valve implants, Eur Heart J, 36, 1297, 10.1093/eurheartj/ehu330
Bussey, 2013, Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin K with genomic considerations: a pilot study, Pharmacotherapy, 33, 1136, 10.1002/phar.1343
Pernod, 2010, French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding), Thromb Res, 126, e167, 10.1016/j.thromres.2010.06.017
Halvorsen, 2017, Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis, Eur Heart J, 38, 1455
Nishimura, 2014, 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Circulation, 129, e521, 10.1161/CIR.0000000000000031
Whitlock, 2012, Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest, 141, e576S, 10.1378/chest.11-2305
Massel, 2013, Antiplatelet and anticoagulation for patients with prosthetic heart valves, Cochrane Database Syst Rev, 4, CD003464
Valgimigli, 2017, The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS), Eur Heart J
Kristensen, 2014, 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: the Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA), Eur Heart J, 35, 2383, 10.1093/eurheartj/ehu282
2006
Karthikeyan, 2013, Urgent surgery compared with fibrinolytic therapy for the treatment of left-sided prosthetic heart valve thrombosis: a systematic review and meta-analysis of observational studies, Eur Heart J, 34, 1557, 10.1093/eurheartj/ehs486
Laplace, 2004, Clinical significance of early thrombosis after prosthetic mitral valve replacement: a postoperative monocentric study of 680 patients, J Am Coll Cardiol, 43, 1283, 10.1016/j.jacc.2003.09.064
Brown, 2012, Early thrombosis risk in patients with biologic valves in the aortic position, J Thorac Cardiovasc Surg, 144, 108, 10.1016/j.jtcvs.2011.05.032
Mylotte, 2015, Transcatheter heart valve failure: a systematic review, Eur Heart J, 36, 1306, 10.1093/eurheartj/ehu388
Makkar, 2015, Possible subclinical leaflet thrombosis in bioprosthetic aortic valves, N Engl J Med, 373, 2015, 10.1056/NEJMoa1509233
Pache, 2016, Early hypo-attenuated leaflet thickening in balloon-expandable transcatheter aortic heart valves, Eur Heart J, 37, 2263, 10.1093/eurheartj/ehv526
Sorajja, 2015, Percutaneous repair of paravalvular prosthetic regurgitation: patient selection, techniques and outcomes, Heart, 101, 665, 10.1136/heartjnl-2014-306270
Dvir, 2014, Transcatheter aortic valve implantation in failed bioprosthetic surgical valves, JAMA, 312, 162, 10.1001/jama.2014.7246
Ye, 2015, Transcatheter aortic and mitral valve-in-valve implantation for failed surgical bioprosthetic valves: an 8-year single-center experience, JACC Cardiovasc Interv, 8, 1735, 10.1016/j.jcin.2015.08.012
Calleja, 2010, Cardiac risk in patients aged >75 years with asymptomatic, severe aortic stenosis undergoing noncardiac surgery, Am J Cardiol, 105, 1159, 10.1016/j.amjcard.2009.12.019
Tashiro, 2014, Perioperative risk of major non-cardiac surgery in patients with severe aortic stenosis: a reappraisal in contemporary practice, Eur Heart J, 35, 2372, 10.1093/eurheartj/ehu044
European Society of Gynecology (ESG), 2011, ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC), Eur Heart J, 32, 3147, 10.1093/eurheartj/ehr218
Elassy, 2014, Urgent cardiac surgery during pregnancy: a continuous challenge, Ann Thorac Surg, 97, 1624, 10.1016/j.athoracsur.2013.10.067